In Vitro fermentation of sugar beet arabino-oligosaccharides by fecal microbiota obtained from patients with ulcerative colitis to selectively stimulate the growth of Bifidobacterium spp. and Lactobacillus spp.

Applied and Environmental Microbiology

Volumn 77, Issue 23, 2011, Pages 8336-8344

  Vigsnæs, Louise Kristine ^a   Holck, Jesper ^a   Meyer, Anne S ^a   Licht, Tine Rask ^a  

^a TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI-INFLAMMATORY RESPONSE; BATCH SYSTEMS; BIFIDOBACTERIUM; FECAL MICROBIOTA; FRUCTO-OLIGOSACCHARIDES; HEALTHY CONTROLS; HUMAN FECAL; IN-VITRO; INFLAMMATORY CONDITIONS; LACTOBACILLUS SPP; MICROBIAL COMMUNITIES; MIXED CULTURES; PREBIOTIC EFFECT; PREBIOTICS; QUANTITATIVE REAL TIME PCR; SHORT-CHAIN FATTY ACIDS; SUGAR BEET PULP; ULCERATIVE COLITIS;

BACTERIA; DISEASES; FERMENTATION; HEALTH RISKS; OLIGOSACCHARIDES; POLYMERASE CHAIN REACTION; SUGAR BEETS; VOLATILE FATTY ACIDS;

FOOD ADDITIVES;

ACETIC ACID DERIVATIVE; OLIGOSACCHARIDE; PREBIOTIC AGENT;

BACTERIUM; DIGESTIVE SYSTEM DISORDER; FECES; FERMENTATION; GROWTH; METABOLITE; MICROBIAL COMMUNITY; POLYMERASE CHAIN REACTION; PUBLIC HEALTH; REAL TIME; SUGAR; SUGAR BEET;

ARTICLE; BEET; BIFIDOBACTERIUM; BIODIVERSITY; CHEMISTRY; FECES; FERMENTATION; GROWTH, DEVELOPMENT AND AGING; HUMAN; ISOLATION AND PURIFICATION; LACTOBACILLUS; METABOLISM; MICROBIOLOGY; PH; REAL TIME POLYMERASE CHAIN REACTION; ULCERATIVE COLITIS;

ACETATES; BETA VULGARIS; BIFIDOBACTERIUM; BIODIVERSITY; COLITIS, ULCERATIVE; FECES; FERMENTATION; HUMANS; HYDROGEN-ION CONCENTRATION; LACTOBACILLUS; OLIGOSACCHARIDES; PREBIOTICS; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 83255188004     PISSN: 00992240     EISSN: 10985336     Source Type: Journal    
DOI: 10.1128/AEM.05895-11     Document Type: Article

References (73)

1. Al-Tamimi, M. A. H. M., R. J. Palframan, J. M. Cooper, G. R. Gibson, and R. A. Rastall. 2006. In vitro fermentation of sugar beet arabinan and arabinooligosaccharides by the human gut microflora. J. Appl. Microbiol. 100:407-414.
2. Andrews, C., et al. 2011. Mesalazine (5-aminosalicylic acid) alters faecal bacterial profiles, but not mucosal proteolytic activity in diarrhoea-predominant irritable bowel syndrome. Aliment. Pharmacol. Ther. 34:374-383.
3. Ardizzone, S. 2003. Ulcerative colitis. In Orphanet encyclopedia. http://www.orpha.net/data/patho/GB/uk-UC.pdf.
4. Bamias, G., M. R. Nyce, S. A. De la Rue, and F. Cominelli. 2005. New concepts in the pathophysiology of inflammatory bowel disease. Ann. Intern. Med. 143:895-904.
5. Binder, V. 1970. A Comparison between clinical state, macroscopic and microscopic appearances of rectal mucosa, and cytologic picture of mucosal exudate in ulcerative colitis. Scand. J. Gastroenterol. 5:627-632.
6. Cherbut, C., C. Michel, and G. Lecannu. 2003. The prebiotic characteristics of fructooligosaccharides are necessary for reduction of TNBS-induced colitis in rats. J. Nutr. 133:21-27.
7. Christl, S. U., H. D. Eisner, G. Dusel, H. Kasper, and W. Scheppach. 1996. Antagonistic effects of sulfide and butyrate on proliferation of colonic mucosa-a potential role for these agents in the pathogenesis of ulcerative colitis. Dig. Dis. Sci. 41:2477-2481.
8. Collado, M. C., J. Meriluoto, and S. Salminen. 2007. In vitro analysis of probiotic strain combinations to inhibit pathogen adhesion to human intestinal mucus. Food. Res. Int. 40:629-636.
9. Delroisse, J. M., et al. 2008. Quantification of Bifidobacterium spp. and Lactobacillus spp. in rat fecal samples by real-time PCR. Microbiol. Res. 163:663-670.
10. Denman, S. E., and C. S. McSweeney. 2006. Development of a real-time PCR assay for monitoring anaerobic fungal and cellulolytic bacterial populations within the rumen. FEMS Microbiol. Ecol. 58:572-582.
11. De Preter, V., H. M. Hamer, K. Windey, and K. Verbeke. 2011. The impact of pre- and/or probiotics on human colonic metabolism: does it affect human health? Mol. Nutr. Food. Res. 55:46-57.
12. Duncan, S. H., P. Louis, J. M. Thomson, and H. J. Flint. 2009. The role of pH in determining the species composition of the human colonic microbiota. Environ. Microbiol. 11:2112-2122.
13. Eckburg, P. B., et al. 2005. Diversity of the human intestinal microbial flora. Science 308:1635-1638.
14. European Food Safety Authority. 2010. Scientific opinion on dietary reference values for carbohydrates and dietary fibre. EFSA J. 8:1-77.
15. Fite, A., et al. 2004. Identification and quantitation of mucosal and faecal desulfovibrios using real time polymerase chain reaction. Gut 53:523-529.
16. Fooks, L. J., and G. R. Gibson. 2002. In vitro investigations of the effect of probiotics and prebiotics on selected human intestinal pathogens. FEMS Microbiol. Ecol. 39:67-75.
17. Fukuda, S., et al. 2011. Bifidobacteria can protect from enteropathogenic infection through production of acetate. Nature 469:543-U791.
18. Gibson, G. R., et al. 1990. Alternative pathways for hydrogen disposal during fermentation in the human colon. Gut 31:679-683.
19. Gibson, G. R. 1999. Dietary modulation of the human gut microflora using the prebiotics oligofructose and inulin. J. Nutr. 129:1438S-1441S.
20. Guo, X., et al. 2008. Development of a real-time PCR method for Firmicutes and Bacteroidetes in faeces and its application to quantify intestinal population of obese and lean pigs. Lett. Appl. Microbiol. 47:367-373.
21. Hart, A. L., et al. 2005. Characteristics of intestinal dendritic cells in inflammatory bowel diseases. Gastroenterology 129:50-65.
22. Heilig, H. G. H. J., et al. 2002. Molecular diversity of Lactobacillus spp. and other lactic acid bacteria in the human intestine as determined by specific amplification of 16S ribosomal DNA. Appl. Environ. Microbiol. 68:114-123.
23. Hellemans, J., G. Mortier, A. De Paepe, F. Speleman, and J. Vandesompele. 2007. qBase relative quantification framework and software for management and automated analysis of real-time quantitative PCR data. Genome Biology. 8(2):R19.
24. Holck, J., et al. 2011. Feruloylated and nonferuloylated arabino-oligosaccha-rides from sugar beet pectin selectively stimulate the growth of Bifidobacterium spp. in human fecal in vitro fermentations. J. Agric. Food. Chem. 59:6511-6519.
25. Hooper, L. V., T. Midtvedt, and J. I. Gordon. 2002. How host-microbial interactions shape the nutrient environment of the mammalian intestine. Annu. Rev. Nutr. 22:283-307.
26. Hotchkiss, A. T., A. Nunez, R. A. Rastall, and G. R. Gibson. December 2010. Growth promotion of beneficial bacteria in gut of human comprises administering composition comprising arabino oligosaccharide as prebiotic. U.S. patent 2010316766-A1.
27. Jacobs, D. M., E. Gaudier, J. van Duynhoven, and E. E. Vaughan. 2009. Non-digestible food ingredients, colonic microbiota and the impact on gut health and immunity: a role for metabolomics. Curr. Drug Metab. 10:41-54.
28. Langholz, E., P. Munkholm, M. Davidsen, and V. Binder. 1994. Course of ulcerative-colitis-analysis of changes in disease-activity over years. Gastroenterology 107:3-11.
29. Langlands, S. J., M. J. Hopkins, N. Coleman, and J. H. Cummings. 2004. Prebiotic carbohydrates modify the mucosa associated microflora of the human large bowel. Gut 53:1610-1616.
30. Lara-Villoslada, F., et al. 2006. Short-chain fructooligosaccharides, in spite of being fermented in the upper part of the large intestine, have antiinflammatory activity in the TNBS model of colitis. Eur. J. Nutr. 45:418-425.
31. Leser, T. D., R. H. Lindecrona, T. K. Jensen, B. B. Jensen, and K. Moller. 2000. Changes in bacterial community structure in the colon of pigs fed different experimental diets and after infection with Brachyspira hyodysenteriae. Appl. Environ. Microbiol. 66:3290-3296.
32. Lindsay, J. O., et al. 2006. Clinical, microbiological, and immunological effects of fructo-oligosaccharide in patients with Crohn's disease. Gut 55: 348-355.
33. Lloyd, D. A. J., et al. 2002. Crohn's disease and ulcerative colitis: divergent trends in hospital admission rates. Health Stat. Q. 16:19-24.
34. Louis, P., and H. J. Flint. 2009. Diversity, metabolism and microbial ecology of butyrate-producing bacteria from the human large intestine. FEMS Microbiol. Lett. 294:1-8.
35. Madsen, K. L., J. S. Doyle, L. D. Jewell, M. M. Tavernini, and R. N. Fedorak. 1999. Lactobacillus species prevents colitis in interleukin 10 gene-deficient mice. Gastroenterology 116:1107-1114.
36. Mandalari, G., et al. 2007. In vitro evaluation of the prebiotic activity of a pectic oligosaccharide-rich extract enzymatically derived from bergamot peel. Appl. Microbiol. Biotechnol. 73:1173-1179.
37. Manning, T. S., and G. R. Gibson. 2004. Microbial-gut interactions in health and disease. Prebiotics. Best Pract. Res. Clin. Gastroenterol. 18:287-298.
38. Matsuki, T., K. Watanabe, J. Fujimoto, T. Takada, and R. Tanaka. 2004. Use of 16S rRNA gene-targeted group-specific primers for real-time PCR analysis of predominant bacteria in human feces. Appl. Environ. Microbiol. 70:7220-7228.
39. Medina, V., J. J. Afonso, H. Alvarez-Arguelles, C. Hernandez, and F. Gonzalez. 1998. Sodium butyrate inhibits carcinoma development in a 1,2-dimethylhydrazine-induced rat colon cancer. JPEN J. Parenter. Enteral. Nutr. 22:14-17.
40. Oosterveld, A., G. Beldman, H. A. Schols, and A. G. J. Voragen. 2000. Characterization of arabinose and ferulic acid rich pectic polysaccharides and hemicelluloses from sugar beet pulp. Carbohydr. Res. 328:185-197.
41. Ott, S. J., et al. 2004. In vitro alterations of intestinal bacterial microbiota in fecal samples during storage. Diagn. Microbiol. Infect. Dis. 50:237-245.
42. Palframan, R. J., G. R. Gibson, and R. A. Rastall. 2002. Effect of pH and dose on the growth of gut bacteria on prebiotic carbohydrates in vitro. Anaerobe 8:287-292.
43. Peran, L., et al. 2007. A comparative study of the preventative effects exerted by three probiotics, Bifidobacterium lactis, Lactobacillus casei and Lactobacillus acidophilus, in the TNBS model of rat colitis. J. Appl. Microbiol. 103:836-844.
44. Petersen, A., et al. 2010. Analysis of the intestinal microbiota of oligosaccharide fed mice exhibiting reduced resistance to Salmonella infection. Benef. Microbes 3:271-281.
45. Qin, J. J., et al. 2010. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464:59-65.
46. Rastall, R. A., and V. Maitin. 2002. Prebiotics and synbiotics: towards the next generation. Curr. Opin. Biotechnol. 13:490-496.
47. Roberfroid, M. 2007. Prebiotics: the concept revisited. J. Nutr. 137:830S-837S.
48. Rodriguez-Cabezas, M. E., et al. 2010. The combination of fructooligosaccharides and resistant starch shows prebiotic additive effects in rats. Clin. Nutr. 29:832-839.
49. Rose, D. J., K. Venema, A. Keshavarzian, and B. R. Hamaker. 2010. Starchentrapped microspheres show a beneficial fermentation profile and decrease in potentially harmful bacteria during in vitro fermentation in faecal microbiota obtained from patients with inflammatory bowel disease. Br. J. Nutr. 103:1514-1524.
50. Rossi, M., et al. 2005. Fermentation of fructooligosaccharides and inulin by bifidobacteria: a comparative study of pure and fecal cultures. Appl. Environ. Microbiol. 71:6150-6158.
51. Rowan, F., et al. 2010. Desulfovibrio bacterial species are increased in ulcerative colitis. Dis. Colon Rectum 53:1530-1536.
52. Roy, M. J., et al. 2009. In vitro studies on the inhibition of colon cancer by butyrate and carnitine. Nutrition 25:1193-1201.
53. Ruas-Madiedo, P., et al. 2010. Exopolysaccharides produced by Lactobacillus and Bifidobacterium strains abrogate in vitro the cytotoxic effect of bacterial toxins on eukaryotic cells. J. Appl. Microbiol. 109:2079-2086.
54. Ruemmele, F. M., et al. 2003. Butyrate induced Caco-2 cell apoptosis is mediated via the mitochondrial pathway. Gut 52:94-100.
55. Rycroft, C. E., M. R. Jones, G. R. Gibson, and R. A. Rastall. 2001. A comparative in vitro evaluation of the fermentation properties of prebiotic oligosaccharides. J. Appl. Microbiol. 91:878-887.
56. Rycroft, C. E., M. R. Jones, G. R. Gibson, and R. A. Rastall. 2001. Fermentation properties of gentio-oligosaccharides. Lett. Appl. Microbiol. 32:156-161.
57. Sanz, M. L., G. R. Gibson, and R. A. Rastall. 2005. Influence of disaccharide structure on prebiotic selectivity in vitro. J. Agric. Food Chem. 53:5192-5199.
58. Sanz, M. L., et al. 2005. In vitro investigation into the potential prebiotic activity of honey oligosaccharides. J. Agric. Food Chem. 53:2914-2921.
59. Sartor, R. B. 2008. Therapeutic correction of bacterial dysbiosis discovered by molecular techniques. Proc. Natl. Acad. Sci. U. S. A. 105:16413-16414.
60. Sartor, R. B. 2006. Mechanisms of disease: pathogenesis of Crohn's disease and ulcerative colitis. Nat. Clin. Pract. Gastroenterol. Hepatol. 3:390-407.
61. Sartor, R. B. 2004. Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics. Gastroenterol. 126:1620-1633.
62. Segain, J. P., et al. 2000. Butyrate inhibits inflammatory responses through NF kappa B inhibition: implications for Crohn's disease. Gut 47:397-403.
63. Shen, J., et al. 2006. Molecular profiling of the Clostridium leptum subgroup in human fecal microflora by PCR-denaturing gradient gel electrophoresis and clone library analysis. Appl. Environ. Microbiol. 72:5232-5238.
64. Sokol, H., et al. 2009. Low counts of Faecalibacterium prausnitzii in colitis microbiota. Inflamm. Bowel Dis. 15:1183-1189.
65. Suzuki, Y., K. Tanaka, T. Nano, T. Asakura, and N. Muramatsu. 2004. Utilization by intestinal bacteria and digestibility of arabino-oligosaccharides in vitro. J. Jpn. Soc. Hortic. Sci. 73:574-579.
66. Thomassen, L. V., L. K. Vigsnaes, T. R. Licht, J. D. Mikkelsen, and A. S. Meyer. 2011. Maximal release of highly bifidogenic soluble dietary fibers from industrial potato pulp by minimal enzymatic treatment. Appl. Microbiol. Biotechnol. 90:873-884.
67. Turroni, F., et al. 2009. Exploring the diversity of the bifidobacterial population in the human intestinal tract. Appl. Environ. Microbiol. 75:1534-1545.
68. Van Laere, K. M. J., R. Hartemink, M. Bosveld, H. A. Schols, and A. G. J. Voragen. 2000. Fermentation of plant cell wall derived polysaccharides and their corresponding oligosaccharides by intestinal bacteria. J. Agric. Food Chem. 48:1644-1652.
69. Vernazza, C. L., B. A. Rabiu, and G. R. Gibson. 2006. Human colonic microbiology and the role of dietary intervention: introduction to prebiotics, p. 1-28. In G. R. Gibson and R. A. Rastall (ed.), Prebiotics: development and application. John Wiley & Sons, Ltd., Chichester, England.
70. Walter, J., et al. 2000. Detection and identification of gastrointestinal Lactobacillus species by using denaturing gradient gel electrophoresis and species-specific PCR primers. Appl. Environ. Microbiol. 66:297-303.
71. Zeuthen, L. H., et al. 2010. Lactobacillus acidophilus induces a slow but more sustained chemokine and cytokine response in naive foetal enterocytes compared to commensal Escherichia coli. BMC Immunol. 11:2.
72. Zocco, M. A., et al. 2006. Efficacy of Lactobacillus GG in maintaining remission of ulcerative colitis. Aliment. Pharmacol. Ther. 23:1567-1574.
73. Zoetendal, E. G., et al. 2002. Mucosa-associated bacteria in the human gastrointestinal tract are uniformly distributed along the colon and differ from the community recovered from feces. Appl. Environ. Microbiol. 68: 3401-3407.